Barclays Capital Raises Price Target for Merck (MRK)
October 19th, 2009

Pharma giant Merck & Co., Inc. (MRK) saw its price target raised, but its earnings estimates lowered on Monday by analysts at Barclays Capital.
Dividend.com archives (articles more than 30 days old) are only available to Dividend.com Premium subscribers.
Sign up for a Dividend.com Premium account for instant access to article archives, stock ratings on over 2,000 dividend-paying stocks, and much more! FREE TRIAL available!




RSS


Looking for stocks that are poised for growth and pay solid dividends? Visit our list of the